Related Experiment Video
Updated: Dec 17, 2025

Exploring the Regulation of Lipid Droplet Catabolism through Lipophagy
Published on: January 31, 2025
Autophagic lipid metabolism sustains mTORC1 activity in TSC-deficient neural stem cells
Chenran Wang1, Michael A Haas2, Fuchun Yang2
1Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, USA. wang2cr@ucmail.uc.edu.
Abstract:
Although mTORC1 negatively regulates autophagy in cultured cells, how autophagy impacts mTORC1 signaling, in particular in vivo, is less clear. Here we show that autophagy supports mTORC1 hyperactivation in NSCs lacking Tsc1, thereby promoting defects in NSC maintenance, differentiation, tumourigenesis, and the formation of the neurodevelopmental lesion of Tuberous Sclerosis Complex (TSC). Analysing mice that lack Tsc1 and the essential autophagy gene Fip200 in NSCs we find that TSC-deficient cells require autophagy to maintain mTORC1 hyperactivation under energy stress conditions, likely to provide lipids via lipophagy to serve as an alternative energy source for OXPHOS. In vivo, inhibition of lipophagy or its downstream catabolic pathway reverses defective phenotypes caused by Tsc1-null NSCs and reduces tumorigenesis in mouse models. These results reveal a cooperative function of selective autophagy in coupling energy availability with TSC pathogenesis and suggest a potential new therapeutic strategy to treat TSC patients.
Insights
Autophagy supports mTORC1 hyperactivation in Tuberous Sclerosis Complex (TSC) cells, driving disease pathology. Inhibiting autophagy reverses TSC defects and reduces tumor formation, offering a potential therapeutic strategy.
Area of Science:
- Cell Biology
- Neuroscience
- Cancer Biology
Background:
- mTORC1 signaling typically inhibits autophagy in cell cultures.
- The in vivo impact of autophagy on mTORC1 signaling, particularly in neurological disorders, remains poorly understood.
Purpose of the Study:
- To investigate the role of autophagy in supporting mTORC1 hyperactivation in Tuberous Sclerosis Complex (TSC) pathogenesis.
- To explore the therapeutic potential of targeting autophagy in TSC.
Main Methods:
- Utilized mouse models lacking Tsc1 and Fip200 in neural stem cells (NSCs).
- Analyzed mTORC1 signaling, autophagy, and lipophagy under energy stress conditions.
- Assessed the effects of inhibiting lipophagy and its downstream pathways on TSC-related phenotypes and tumorigenesis.
Main Results:
- Autophagy is required to maintain mTORC1 hyperactivation in Tsc1-deficient NSCs, especially under energy stress.
- Lipophagy provides lipids as an alternative energy source for oxidative phosphorylation (OXPHOS) in TSC-deficient cells.
- Inhibition of lipophagy or its catabolic pathway ameliorated defective phenotypes and reduced tumorigenesis in vivo.
Conclusions:
- Selective autophagy cooperates with energy availability to drive TSC pathogenesis.
- Targeting lipophagy presents a potential therapeutic strategy for TSC patients.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Delivery Pathways to the Lysosome
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...

